Abiopharma

🔍 Watts John C (Executive)

Company: CURTISS WRIGHT CORP (CW)

Report Date: 2026-08-27

Detailed Transactions and Holdings:

• Sold 1,035 shares of Common Stock at $619.46 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,736.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: The reporting person contributed Issuer common stock ("Common Stock") to an exchange fund in exchange for shares of the exchange fund. For purposes of determining the number of shares of the exchange fund issuable pursuant to such exchange, the Common Stock was valued at $619.46 per share, which was the closing price of the Common Stock on the New York Stock Exchange on August 26, 2026. The transaction with the exchange fund closed on August 27, 2025.